Claritev (NYSE:CTEV) reported quarterly losses of $(3.49) per share which beat the analyst consensus estimate of $(4.21) by 17.1 percent. This is a 8.4 percent increase over losses of $(3.81) per share from the same period last year. The company reported quarterly sales of $257.478 million which beat the analyst consensus estimate of $244.813 million by 5.17 percent. This is a 6.59 percent increase over sales of $241.570 million the same period last year.